Neuropsychological Assessment of Cognitive Decline in Patients With a Definite Parkinson's Disease
Characteristics of Cognitive Decline During Parkinson's Disease in the Elderly
1 other identifier
observational
40
1 country
1
Brief Summary
Cognitive disorders in Parkinson's disease (PD) are not as obvious as cognitive disorders in Alzheimer disease and their diagnosis tends to be delayed. If neuropsychological assessment of cognitive decline in Parkinson's disease is well established, the thresholds of cognitive testing corresponding to a dementia are unknown. Recently, new diagnosis criteria of dementia associated with PD have been proposed by the movement disorder society. In this study two groups of patients with idiopathic PD will be separated and compared according to their Mini Mental State Examination (MMSE) score (upper or lower than 26). Included patients will have clinically idiopathic PD, will be over 65 years old and will present cognitive complain. Cognitive and mood disorders as well as motor symptoms will be assessed using validated scales and a neuropsychological assessment dispatched in two visits will be performed . Differences in the distribution of data from the two groups of patients will be assessed in statistically analysis with non parametric tests. The purpose of this study is to determine the most effective tests and their threshold value corresponding to a pathological cognitive decline.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2010
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 27, 2010
CompletedFirst Posted
Study publicly available on registry
April 29, 2010
CompletedStudy Start
First participant enrolled
June 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2012
CompletedFebruary 5, 2020
November 1, 2010
2.2 years
April 27, 2010
January 30, 2020
Conditions
Keywords
Study Arms (2)
A:
Patients with idiopathic PD and with MMSE \< à 26
B:
Patients with idiopathic PD and with MMSE ≥ à 26
Interventions
Included patients had clinically idiopathic PD, were over 65 years old and presented with a cognitive complain. A detailed registration of clinical history (including review of motor, cognitive, and neuropsychiatric symptoms, comorbid medical conditions, and medications) and neurologic examination was performed. Exclusion criteria included other conditions than PD that could contribute substantially to the subject's motor and/or cognitive impairment, including neurologic and major psychiatric disorders ( delirium,…) affecting the cognitive functions. Patients with major cognitive impairment (i.e. Mental State Examination (MMSE) \<16/30) were also excluded.). Neuropsychological assessment explores working memory, episodic memory ,verbal fluency, executive functions and visuo constructive functions.
Eligibility Criteria
Patients with idiopathic PD are issued from an ambulatory following at the department of Geriatrics
You may qualify if:
- MMSE ≥ 16
- impact of cognitive disorders in daily living
- criteria of the UKPDSBB for PD
- steady state in PD
- benign delusions or treated psychosis are tolerated
- informed consent obtained
You may not qualify if:
- dementia from other origin than PD
- cognitive decline without impact on daily living
- MMSE \< 16
- delirium in the last 3 months
- Severe Depression
- Central Anticholinergic medication
- inability to perform the cognitive testing
- major cerebrovascular disease
- inability to give an informed consent (patients with protective measures)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Service de Gériatrie, Hôpital de la Robertsau, Hôpitaux Universitaires de Strasbourg
Strasbourg, 67091, France
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michèle Kiesmann, MD
University Hospital, Strasbourg, France
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 27, 2010
First Posted
April 29, 2010
Study Start
June 1, 2010
Primary Completion
August 1, 2012
Study Completion
September 1, 2012
Last Updated
February 5, 2020
Record last verified: 2010-11